Back
Catalyst Pharmaceuticals Stock Price Chart
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
66
CPRX
Catalyst Pharmaceuticals
Last Price:
$22.05
Seasonality Move:
8.47%
7 Day Trial
ALL ACCESS PASS
$
7
This is going to be BIG...
You can get in on the action now by following this link.-
The current trend is moderately bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Catalyst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.64 | Sell |
| 20-day SMA: | 23.46 | Sell |
| 50-day SMA: | 22.75 | Sell |
| 200-day SMA: | 20.73 | Buy |
| 8-day EMA: | 22.2 | Sell |
| 20-day EMA: | 18.93 | Buy |
| 50-day EMA: | 11.59 | Buy |
| 200-day EMA: | 3.7 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.51 | Buy |
| Relative Strength Index (14 RSI): | 45.06 | Sell |
| Chaikin Money Flow: | 927465 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.46 - 24.56) | Sell |
| Bollinger Bands (100): | (21.15 - 23.41) | Sell |
Catalyst Pharmaceuticals Technical Analysis
| Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 22.05 while CPRX 8-day simple moving average is 22.64, which is a Sell signal.
-
The stock price of CPRX is 22.05 while Catalyst Pharmaceuticals 20-day SMA is 23.46, which makes it a Sell.
-
Catalyst Pharmaceuticals 50-day simple moving average is 22.75 while CPRX share price is 22.05, making it a Sell technically.
-
CPRX stock price is 22.05 and Catalyst Pharmaceuticals 200-day simple moving average is 20.73, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
66
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a BuyThe current Catalyst Pharmaceuticals [CPRX] share price is $22.05. The Score for CPRX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
2.7B
Price in USD:
22.05
Share Volume:
1.1M
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
26.16
52-Week Low:
14.47
Buy
66
Catalyst Pharmaceuticals (CPRX)
is a Buy
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?The Catalyst Pharmaceuticals stock price is 22.05 USD today.
-
Will CPRX stock go up or go down?Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Catalyst Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is not overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 22.05 while CPRX 8-day exponential moving average is 22.20, which is a Sell signal.
-
The stock price of CPRX is 22.05 while Catalyst Pharmaceuticals 20-day EMA is 18.93, which makes it a Buy.
-
Catalyst Pharmaceuticals 50-day exponential moving average is 11.59 while CPRX share price is 22.05, making it a Buy technically.
-
CPRX stock price is 22.05 and Catalyst Pharmaceuticals 200-day simple moving average is 3.70, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.37 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
-
CPRX Moving Average Covergence Divergence (MACD) indicator is 4.51, suggesting Catalyst Pharmaceuticals is a Buy
-
Catalyst Pharmaceuticals Relative Strength Index (RSI) is 45.06, which suggest Catalyst Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Catalyst Pharmaceuticals is (21.46 - 24.56), which suggest Catalyst Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Catalyst Pharmaceuticals is (21.15 - 23.41), which suggest Catalyst Pharmaceuticals is a Sell
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.